Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer
1996

Preoperative CYFRA 21-1 Level as a Prognostic Indicator in Lung Cancer

Sample size: 91 publication Evidence: high

Author Information

Author(s): J Niklinskil, M Furman, T Burzykowski, L Chyczewski, J Laudanskil, E Chyczewska, M Rapellino

Primary Institution: Bialystok Medical Academy, Bialystok, Poland

Hypothesis

Is elevated preoperative CYFRA 21-1 level prognostically significant in patients with resected primary squamous-cell lung cancer?

Conclusion

Elevated preoperative CYFRA 21-1 levels may indicate a higher risk of treatment failure and poor survival in patients with squamous-cell lung cancer.

Supporting Evidence

  • 55% of patients had elevated CYFRA 21-1 levels.
  • Elevated levels were significantly associated with poor overall survival.
  • Multivariate analysis confirmed elevated levels were linked to poor survival outcomes.

Takeaway

Doctors can use a blood test called CYFRA 21-1 to help predict how well patients with lung cancer will do after surgery.

Methodology

Serum levels of CYFRA 21-1 were measured in 91 patients using an immunoradiometric assay, and survival analyses were conducted using Kaplan-Meier and log-rank tests.

Limitations

The study did not include patients who underwent chemotherapy or radiation therapy before surgery.

Participant Demographics

Patients were diagnosed with squamous-cell lung cancer and had a good performance status at the time of surgery.

Statistical Information

P-Value

P=0.0001 for TNM stage, P<0.00005 for overall survival and disease-free survival in univariate analysis.

Confidence Interval

95% CI for overall survival was 0.346-0.638.

Statistical Significance

p<0.00005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication